Unintentional weight loss (unexplained weight loss)
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
First-line tests
Fasting laboratory tests
- FBC
- CRP
- Serum electrolytes
- Serum calcium
- Serum creatinine with eGFR
- Fasting plasma glucose
- AST
- ALT
- GGT
- Alkaline phosphatase
- TSH
- Serum albumin (severity of undernutrition)
- LDHif needednon-French guidelineWeight loss still unexplained after clinical examination: LDH is part of the initial tests proposed by the AAFP [2].
- Serum protein electrophoresisif needednon-French guidelineWeight loss still unexplained after clinical examination: protein electrophoresis is part of the initial tests proposed by the AAFP [2].
- Serum ferritinif needednon-French guidelineUnexplained weight loss, especially with anaemia: ferritin is part of the initial tests proposed by the AAFP [2]; unexplained iron deficiency also prompts a search for coeliac disease [3].
- Vitamin B12if needednon-French guidelineWeight loss still unexplained after clinical examination: the 2025 Scottish guidelines on non-specific symptoms of cancer cite vitamin B12, ferritin and folate among the useful tests, in an indicative list that is not a minimum [4]. The AAFP initial tests retain ferritin, without B12 or folate [2].
- Folateif needednon-French guidelineWeight loss still unexplained after clinical examination: the 2025 Scottish guidelines on non-specific symptoms of cancer cite vitamin B12, ferritin and folate among the useful tests, in an indicative list that is not a minimum [4]. The AAFP initial tests retain ferritin, without B12 or folate [2].
- HIV serology (if risk factor or never screened)if needednon-French guidelineRisk factor for exposure, fever, sweats, lymphadenopathy: HIV and tuberculosis are among the infectious causes of weight loss [2].
- Total IgAif needednon-French guidelineUnexpected weight loss, especially with digestive symptoms, fatigue or iron, B12 or folate deficiency: NICE recommends coeliac disease serology, on a gluten-containing diet for at least 6 weeks [3].
- IgA anti-tissue transglutaminase antibodies (tTG-IgA)if needednon-French guidelineUnexpected weight loss, especially with digestive symptoms, fatigue or iron, B12 or folate deficiency: NICE recommends coeliac disease serology, on a gluten-containing diet for at least 6 weeks [3].
- Total PSA (man with urinary symptoms, erectile dysfunction or haematuria)if needednon-French guidelineMan with lower urinary tract symptoms, erectile dysfunction or macroscopic haematuria: NICE proposes PSA and digital rectal examination; PSA is not linked to weight loss alone [5].
- CA 125 (woman aged 40 or over, if symptoms suggestive of ovarian cancer)if needednon-French guidelineWoman with unexplained weight loss, fatigue or bowel disturbance: NICE proposes considering tests for ovarian cancer; from age 40, CA 125 then pelvic ultrasound depending on the threshold; before age 40, ultrasound without CA 125 alone [5].
Urine tests
- Urine dipstick
Imaging
- Chest X-ray
Do not order
Sources (9)
- Haute Autorité de santé, Fédération française de nutrition. Diagnostic de la dénutrition chez l'enfant, l'adulte et la personne de 70 ans et plus. Fiche outil, novembre 2021 (recommandations de novembre 2019 et novembre 2021).
- Gaddey HL, Holder KK. Unintentional weight loss in older adults. Am Fam Physician. 2021;104(1):34-40.
- National Institute for Health and Care Excellence. Coeliac disease: recognition, assessment and management. NICE guideline NG20, 2015, recommandations 1.1.1 à 1.2.2.
- Centre for Sustainable Delivery (NHS Scotland). Scottish referral guidelines for suspected cancer, 2025 : Non-specific symptoms of cancer (Right Decision Service).
- National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. NICE guideline NG12, 2015, mise à jour du 15 avril 2026 : recommandations par symptôme (perte de poids) et par site (1.3.1, 1.5.3, 1.6.2, 1.13.2).
- Nicholson BD, Virdee P, Aveyard P, et al. Prioritising primary care patients with unexpected weight loss for cancer investigation: diagnostic accuracy study (update). BMJ. 2024;387:e080199 (version corrigée remplaçant l'article rétracté BMJ 2020;370:m2651).
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 1577 (HbA1c), 7325 (CA 125), 1828 (anti-transglutaminase) ; absence d'acte pour la VS.
- Bosch X, Monclús E, Escoda O, Guerra-García M, Moreno P, Guasch N, López-Soto A. Unintentional weight loss: clinical characteristics and outcomes in a prospective cohort of 2677 patients. PLoS One. 2017;12(4):e0175125.
- Region Midtjylland (Danemark). Diagnostisk pakkeforløb, Region Midtjylland : forløbsbeskrivelse pour la médecine générale (sundhed.dk), mise à jour du 18 juin 2025 ; déclinaison régionale du parcours national de la Sundhedsstyrelsen.